Clinical Data

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Rhythm’s obesity pill trial hits primary goal, sending stock up

A phase 2 trial of the biotech’s next-generation oral candidate hit its primary endpoint, sending the stock up 26%.
Nick Paul Taylor Jul 9, 2025 10:21am
Goal disorientation and lack of vision

UPDATED: Taiho’s discontinues ph. 3 trial after DMD miss

Jul 8, 2025 10:17am
Human kidney anatomy

ProKidney cell therapy wins half of trial, falls short on other

Jul 8, 2025 8:00am
data error magnifying glass inspection mistake

Jasper warns of restructuring after dud drug derails trials

Jul 7, 2025 9:23am
Graphic image of an arrow nailing the bullseye of a target

Cogent hits primary endpoint, building case for Blueprint rival

Jul 7, 2025 9:16am
eczema atopic dermatitis Black African American patient skin of color

Apogee claims IL-13 antibody sets new eczema treatment standard

Jul 7, 2025 8:29am